UiPath (NYSE:PATH) Shares Down 0.4%

Shares of UiPath Inc. (NYSE:PATH) fell 0.4% during trading on Friday . The company traded as low as $18.79 and last traded at $18.97. 1,170,693 shares changed hands during trading, a decline of 87% from the average session volume of 8,853,152 shares. The stock had previously closed at $19.04.

Wall Street Analyst Weigh In

A number of brokerages have commented on PATH. KeyCorp began coverage on shares of UiPath in a research note on Monday, April 8th. They set an “overweight” rating and a $27.00 price target for the company. Truist Financial reaffirmed a “buy” rating and set a $32.00 price objective on shares of UiPath in a report on Wednesday, March 20th. Scotiabank lifted their price objective on shares of UiPath from $29.00 to $30.00 and gave the stock a “sector perform” rating in a report on Thursday, March 14th. JPMorgan Chase & Co. raised shares of UiPath from a “neutral” rating to an “overweight” rating and lifted their price objective for the stock from $22.00 to $28.00 in a report on Thursday, March 14th. Finally, TD Cowen lifted their price objective on shares of UiPath from $25.00 to $28.00 and gave the stock an “outperform” rating in a report on Thursday, March 14th. Nine equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the company. Based on data from MarketBeat, UiPath currently has an average rating of “Moderate Buy” and an average target price of $27.41.

UiPath Trading Down 1.7 %

The stock’s fifty day moving average is $22.97 and its two-hundred day moving average is $21.44. The company has a market capitalization of $10.65 billion, a PE ratio of -111.58 and a beta of 0.96.

UiPath (NYSE:PATH) last released its quarterly earnings data on Wednesday, March 13th. The healthcare company reported $0.06 EPS for the quarter, beating the consensus estimate of ($0.04) by $0.10. The business had revenue of $405.25 million for the quarter, compared to the consensus estimate of $383.32 million. UiPath had a negative net margin of 6.87% and a negative return on equity of 3.29%. As a group, analysts anticipate that UiPath Inc. will post -0.04 EPS for the current fiscal year.

Insider Buying and Selling at UiPath

In other UiPath news, CFO Ashim Gupta sold 40,000 shares of the company’s stock in a transaction dated Thursday, April 4th. The shares were sold at an average price of $21.66, for a total transaction of $866,400.00. Following the sale, the chief financial officer now directly owns 660,762 shares of the company’s stock, valued at $14,312,104.92. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Insiders have sold a total of 72,000 shares of company stock valued at $1,591,360 over the last three months. 31.03% of the stock is currently owned by insiders.

Institutional Investors Weigh In On UiPath

Hedge funds and other institutional investors have recently modified their holdings of the stock. Royal London Asset Management Ltd. increased its position in shares of UiPath by 5.9% during the third quarter. Royal London Asset Management Ltd. now owns 139,544 shares of the healthcare company’s stock valued at $2,388,000 after buying an additional 7,742 shares during the period. O Shaughnessy Asset Management LLC bought a new stake in shares of UiPath during the third quarter valued at about $203,000. Invesco Ltd. increased its position in shares of UiPath by 2.8% during the third quarter. Invesco Ltd. now owns 399,181 shares of the healthcare company’s stock valued at $6,830,000 after buying an additional 10,863 shares during the period. Symmetry Partners LLC bought a new position in shares of UiPath in the fourth quarter worth approximately $205,000. Finally, Toroso Investments LLC increased its position in shares of UiPath by 196.7% in the third quarter. Toroso Investments LLC now owns 78,189 shares of the healthcare company’s stock worth $1,338,000 after purchasing an additional 51,834 shares during the last quarter. 62.50% of the stock is currently owned by institutional investors.

UiPath Company Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, and Japan. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.